# Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia

> **NCT06882525** · NA · NOT_YET_RECRUITING · sponsor: **Ankara City Hospital Bilkent** · enrollment: 76 (estimated)

## Conditions studied

- Herpes Zoster
- Neuralgia, Postherpetic

## Interventions

- **PROCEDURE:** Lidocaine (drug)

## Key facts

- **NCT ID:** NCT06882525
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-07
- **Primary completion:** 2025-09-07
- **Final completion:** 2025-12-06
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06882525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06882525, "Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06882525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
